Antivirals for COVID-19: A critical review

No specific drugs have been approved for coronavirus disease 2019 (COVID-19) to date as the development of antivirals usually requires time. Therefore, assessment and use of currently available antiviral drugs is critical for a timely response to the current pandemic. Here, we have reviewed anti-SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Frediansyah, Andri, Tiwari, Ruchi, Sharun, Khan, Dhama, Kuldeep, Harapan, Harapan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of INDIACLEN. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831805/
https://www.ncbi.nlm.nih.gov/pubmed/33521390
http://dx.doi.org/10.1016/j.cegh.2020.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831805/
https://www.ncbi.nlm.nih.gov/pubmed/33521390
http://dx.doi.org/10.1016/j.cegh.2020.07.006

Ejemplares similares